Vendas +55 (81) 3231.0614 -

Inhibition of Restenosis in Femoropopliteal Arteries

Inhibition of Restenosis in Femoropopliteal Arteries Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial

In this pilot trial, paclitaxel balloon coating caused no obvious adverse events and reduced restenosis in atients undergoing angioplasty of femoropopliteal arteries.


Veja também

IN.PACT ADMIRAL DRUG-COATED BALLOON OUTPERFORMS STANDARD ANGIOPLASTY IN LANDMARK STUDY When Not to Implant the Multilayer Flow Modulator: Lessons Learned From Application Outside the Indications for Use in Patients With Thoracoabdominal Pathologies Estudo do balão farmacológico Pacific In.pact Multilayer Stent Drug-Eluting Ballons in the SFA Invatec: Translating Global Success in Vascular Devices to the US Market Experience With Thoracic Endovascular Aortic Endovascular repair of Abdominal Aortic Aneurysm